TGFB1 and nasopharyngeal carcinoma: Ma et al. revealed that TGF-β1 could activate c-Jun/STT3A signaling pathway to promote N-glycosylation of PD-L1, thus allowing immune evasion and hampering the efficacy of PD-1/PD-L1 inhibition in NPC cells.